Atrial Fibrillation Trial, Recruiting NCT05795842 Sponsor: Emory University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05795842
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 55 years of age or older
  • You have recently been discharged from hospital after having an ischemic stroke (a stroke caused by a blood clot) where doctors were not able to find the exact cause
  • You are receiving follow-up care at the Emory Stroke Clinic
  • Your doctor has already recommended that you wear a heart monitor for an extended period as part of your normal care
  • You, or a legally authorized person acting on your behalf, are willing and able to give consent to participate
  • You, a family member, or your caregiver can understand English and follow the instructions for using and charging the study wrist device

Who may not be able to join:

  • You are younger than 55 years of age at the time of joining the study
  • Your doctor has not recommended extended heart monitoring as part of your care
  • Neither you, a family member, nor your caregiver is able to understand English or follow the instructions for the study wrist device
  • You have been diagnosed with a heart valve problem, an infection of the heart (endocarditis), a buildup in the main artery from the heart (aortic arch atheroma greater than 3mm), a blood clotting disorder, a condition requiring lifelong use of blood thinners, or an active cancer
  • You, or a legally authorized person acting on your behalf, are unwilling or unable to give consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiao Hu, PhD, Emory University, School of Nursing

Phone: 404-712-8520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 March 2023
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sensitivity and specificity for detecting AF with PPG; The algorithm concordance index or c-index for predicting AF compared with EHR data

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov